The Claim
In human mesenchymal stromal cells cultured under calcifying conditions, atorvastatin at concentrations of 0.1–1 μM inhibits mineral deposition, while in human smooth muscle-like cells derived from mesenchymal stromal cells, the same concentration range promotes calcification.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In laboratory cultures, atorvastatin reduces mineral buildup in human mesenchymal stromal cells but increases mineral buildup in human smooth muscle-like cells derived from the same cell type.
See the scientific wording
In human mesenchymal stromal cells cultured under calcifying conditions, atorvastatin at concentrations of 0.1–1 μM inhibits mineral deposition, while in human smooth muscle-like cells derived from mesenchymal stromal cells, the same concentration range promotes calcification, indicating cell-type-specific responses to statin exposure in vitro.
Atorvastatin blocks a key enzyme that makes building blocks for cell signaling molecules. In some cells, this stops them from turning into bone-like cells and reduces calcium buildup. In other cells, the same block causes them to switch into bone-like cells instead, increasing calcium deposits. The difference depends on the cell's original identity and how it responds to the loss of those signaling molecules.
What the research says
1 studyIn lab-grown cells, atorvastatin stops calcium buildup in some cells but makes it worse in others, showing the drug doesn’t affect all cells the same way.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.